D&K Healthcare Resources, Inc. (NASDAQ: DKHR) announced today that due to lower sales in the national account trade class and lower gross profit margins in the independent and regional pharmacies trade class it expects to report a net loss per diluted share of between $(0.14) and $(0.16) for the quarter ended September 30, 2004. The Company’s first fiscal quarter is historically the lowest in volume and gross profit and was further negatively impacted by a lack of price increases by pharmaceutical manufacturers and a slower than anticipated transition from a “buy and hold” to a “fee for service” industry model.
